HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yates, K. E. Articles by Gasson, J. C. Search for Related Content PubMed PubMed Citation Articles by Yates, K. E. Articles by Gasson, J. C.

Role of c-Fes in Normal and Neoplastic Hematopoiesis

^a Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, Los Angeles, California, USA;
^b Department of Biological Chemistry, UCLA School of Medicine, Los Angeles, California, USA

Key Words. c-Fes • Tyrosine kinase • Hematopoiesis • c-Fps • Signal transduction • Leukemia

Dr. Judith C. Gasson, Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90095-1678, USA.

The study of oncogenes has provided numerous insights, not only into the mechanisms by which growth regulation becomes uncontrolled in cancer cells, but also into signal transduction processes which regulate the orderly proliferation and maturation of cells. c-fes/fps is a cellular oncogene which has been transduced frequently by mammalian and avian retroviruses. There are several features about Fes which suggest it may play a unique role in myeloid cell growth and differentiation. While it contains a tyrosine kinase and SH2 domain, there is no SH3 domain or carboxy terminal regulatory phosphotyrosine such as found in the Src family of kinases. Fes has a unique N-terminal domain of over 400 amino acids of unknown function. It has been implicated in signaling by a variety of hematopoietic growth factors, and is predominantly a nuclear protein.

This article has been cited by other articles:

				S. Neri, A. Gardini, A. Facchini, F. Olivieri, C. Franceschi, G. Ravaglia, and E. Mariani Mismatch Repair System and Aging: Microsatellite Instability in Peripheral Blood Cells From Differently Aged Participants J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 285 - 292. [Abstract] [Full Text] [PDF]

				H. Jiang, K. Foltenyi, M. Kashiwada, L. Donahue, B. Vuong, B. Hehn, and P. Rothman Fes Mediates the IL-4 Activation of Insulin Receptor Substrate-2 and Cellular Proliferation J. Immunol., February 15, 2001; 166(4): 2627 - 2634. [Abstract] [Full Text] [PDF]

				Y. Senis, R. Zirngibl, J. McVeigh, A. Haman, T. Hoang, and P. A. Greer Targeted Disruption of the Murine fps/fes Proto-Oncogene Reveals that Fps/Fes Kinase Activity Is Dispensable for Hematopoiesis Mol. Cell. Biol., November 1, 1999; 19(11): 7436 - 7446. [Abstract] [Full Text] [PDF]